SGT-151 or CUMYL-PeGaCLONE are the abbreivated names for 5-pentyl-2-(1-methyl-1-phenyl-ethyl)-2,5-dihydro-pyrido[4,3-b]indol-1-one, which is one of the new generation of novel synthetic cannabinoids, that is uncontrolled at present in most of the EU for use in laboratory research.

PLEASE NOTE: This compound has an extremely high in-vitro affinity for the CB1 receptor, even higher than 5F-ADB. Please ensure laboratory safety procedures are followed, and respirator masks and gloves are used when handling.

The crucial factor of the SGT-151 molecule from a regulatory perspective is the ring and bridge are incorporated into the same sub-structure. This ensures it falls out of the generic controls used by some EU countries such as Germany, where the generic control is based on the JWH-018 "4 substructure" template.

As ever, with so little known about its chemical properties, it offers a fantastic opportunity for researchers and chemistry hobbyists to conduct interesting experiments and lead the way in determining the essential chemical and physical properties of the compound such as melting points and solublities etc.